Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Tip of the hat to Mugs
View:
Post by Pragmatist on Feb 09, 2021 11:58pm

Tip of the hat to Mugs

 
 
He was the first to suggest China as an early regional partner.  Many of us expected one of the remaining BRIC countires.  But we were more focused on LATAM.  Good call!
Comment by MrMugsy on Feb 10, 2021 12:08am
Thanks Pragmatist. I recalled Dan saying they had a lawyer familiar with Chinese partnerships - that made me think China was always in the running. Luck of the draw !!!!
Comment by HarveyTwoface on Feb 10, 2021 3:35am
Well, Dan mentioned certain countries in the last BioPub when saying there are different NSAID brands who are market leaders in those countries (probably bc these are the deals they're working on first), in order 1. USA (this one we'll have to wait for), 2. China (done deal), 3. Brazil (probably next deal w LATAM). I think Dan had some Freudian slip there in mentioning them in this order ...more  
Comment by MikeStock on Feb 10, 2021 7:35am
Thanks Mugs for your valued and informed opinions. Cheers all. 
Comment by 3burtc on Feb 10, 2021 7:56am
Yes, thanks mugs, sorry or putting you on ignore.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities